10-Q: Quarterly report
ExcelFin Acquisition Corp. Announces Increase in Extension Payment
ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the special meeting of the stockholders of the Company...
ExcelFin Acquisition Corp. Announces 30-day Extension of Extension Proposal
ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that (i) the special meeting of the stockholders of the Company...
ExcelFin Acquisition, Baird: Updated Transaction Terms in Part Driven by Baird Medical's Lower Than Expected 2023 Results
ExcelFin Acquisition, Baird: Updated Transaction Terms in Part Driven by Baird Medical's Lower Than Expected 2023 Results
Baird Medical Agreed to Subject 30% of Its Shrs to Be Received in Transaction to Earnout at $12.50 Trading Price
Baird Medical Agreed to Subject 30% of Its Shrs to Be Received in Transaction to Earnout at $12.50 Trading Price
ExcelFin Acquisition, Baird: Minimum Cash Condition of $15 M Has Been Waived >XFIN
ExcelFin Acquisition, Baird: Minimum Cash Condition of $15 M Has Been Waived >XFIN
Baird Medical Is Expected to Trade on Nasdaq Under Ticker BDMD Upon Closing
Baird Medical Is Expected to Trade on Nasdaq Under Ticker BDMD Upon Closing
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment With Hldrs
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment With Hldrs
ExcelFin Acquisition Merger Partner Baird Medical Devices Subsidiary, Betters (Suzhou) Medical Has Received FDA Clearance To Begin Marketing Its Microwave Ablation Systems In The U.S.
https://www.sec.gov/Archives/edgar/data/1852749/000110465923120475/tm2331380d1_425.htm
ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the Special Meeting originally scheduled for October 18, 2023 (the "Spec
Baide Healthcare's plan to go public with ExcelFin (XFIN.US) in the US was previously suspended on the eve of its listing in Hong Kong
The Zhitong Finance App learned that on June 26, the Chinese medical technology company Baide Medical announced that it plans to merge with ExcelFin Acquisition Corp. (XFIN.US), a special purpose acquisition company (SPAC). After the merger is completed, the company will operate as Baird Medical Investment Holdings Limited and be listed on the NASDAQ under the stock code “BDMD.” According to the merger agreement, the equity value before the merger was 300 million US dollars, and the company's implied estimated corporate price after the merger
Chinese Medtech Baird Medical to Go Public Through SPAC Merger
Sector Update: Health Care Stocks Declining Monday Afternoon
Health care stocks were lower on Monday afternoon, with the NYSE Health Care Index falling 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%. The iShares Biotechnology ETF (IBB) was dec
ExcelFin Acquisition Corp. to Take Baird Medical Investment Holdings Public in Merger Deal
ExcelFin Acquisition Corp. (XFIN) and Baird Medical Investment Holdings Ltd. said Monday they plan to merge, with Baird taken public through the deal with the special purpose investment company. The c
Baird Medical to List on Nasdaq Via Combination With SPAC ExcelFin
By Robb M. Stewart Medical-technology company Baird Medical Investment Holdings will combine with blank-check investor ExcelFin Acquisition in a deal to become publicly listed on Nasdaq. The compani
ExcelFin Acquisition :The Combined Co Will Operate as Baird Medical Investment Holdings Limited and Be Listed on the Nasdaq Under the New Ticker Symbol BDMD >XFIN
ExcelFin Acquisition :The Combined Co Will Operate as Baird Medical Investment Holdings Limited and Be Listed on the Nasdaq Under the New Ticker Symbol BDMD >XFIN
Baird Medical, a Leading Developer and Provider of Microwave Ablation Medical Devices in China, to Be Publicly Listed on NASDAQ Through a Proposed Business Combination With ExcelFin Acquisition Corp.
Baird Medical, a Leading Developer and Provider of Microwave Ablation Medical Devices in China, to Be Publicly Listed on NASDAQ Through a Proposed Business Combination With ExcelFin Acquisition Corp.
ExcelFin Acquisition: Proposed Transaction Represents a Pre-Money Equity Value of $300 M for Baird Medical and an Implied Pro Forma Enterprise Value of Approximately $370 M for the Combined Compan >XFIN
ExcelFin Acquisition: Proposed Transaction Represents a Pre-Money Equity Value of $300 M for Baird Medical and an Implied Pro Forma Enterprise Value of Approximately $370 M for the Combined Compan >XF
Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to Be Publicly Listed on NASDAQ Through a Proposed Business Combination With ExcelFin Acquisition Corp.
Baird Medical Investment Holdings Limited (NASDAQ: XFIN) have entered into a definitive business combination agreement that would result in Baird Medical becoming a publicly traded company.
ExcelFin Acquisition Corp Shares Halted, News Pending
ExcelFin Acquisition Corp Shares Halted, News Pending
No Data